New Rheumatoid Arthritis Treatment on the Way?

Article

Stiff and swollen joints may land some relief due to a newly discovered anti-inflammatory chemical compound.

Stiff and swollen joints may land some relief due to a newly discovered anti-inflammatory chemical compound.

A team from Montana State University acknowledged that some patients with rheumatoid arthritis (RA) do not respond to the currently available biological drugs, or “biologics” — either for a certain amount of time or forever. Stemming from the Department of Microbiology and Immunology, the researchers identified a compound that could lead to a treatment for the autoimmune disease.

“There is a real need to develop new kinds of drugs that are different,” senior author Mark Quinn, a MSU professor, said in a news release.

The researchers used a collagen-induced arthritis model to report on the effects of IQ-IS in mice. Published in The Journal of Pharmacology and Experimental Therapeutics, the team synthesized the sodium salt of IQ-IS which proved to cause a delay of c-Jun N-terminal kinases (JNKs) — a key player in T cell differentiation.

“Here we show that IQ-1S is highly specific for JNK and that its neutral form is the most abundant species at physiologic pH,” the authors wrote.

Using the chemical compound increased the number of regulatory T cells in the lymph nodes which is a reaction that suppresses inflammation. Furthermore, specific collagen-induced arthritis related antibodies also responded to the IQ-IS.

“Treatment with IQ-1S either before or after induction of CIA resulted in decreased clinical scores,” the study confirmed. “And joint sections from IQ-IS-treated CIA mice exhibited only mild signs of inflammation and minimal cartilage loss compared with those from control mice.”

Not only did the experiment find that IQ-IS eases inflammation, but it also inhibitors the loss of cartilage and bone. This new chemical compound could lead to medications that work with current drugs or serve as contemporary treatments.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.